Cornelia Fuller

Cornelia Fuller, MBA, is currently the Global Insights Lead for Rare Disease at Amgen, where they drive strategic insights in new product planning. Previously, Cornelia held several key roles including Associate Director of Market Insights at Merck and Associate Director of Market Intelligence at Bayer, focusing on oncology and neurology respectively. Cornelia also served as the US market research lead for a cholesterol-lowering monoclonal antibody at Sanofi. Earlier in their career, they worked as a Market Research Manager at Pfizer Consumer Healthcare and AT&T. Cornelia is pursuing a BA in Psychology from Seton Hall University and an MBA from Rutgers Business School.